News & Perspective

Feb 09, 2018

Feb 09, 2018

ASP Scan (Weekly) for Feb 09, 2018

Research agenda for antibiotic resistance
Antibiotics for aspiration pneumonitis
Stewardship in kids' pneumonia
Resistant yaws
Antibiotic-resistant Campylobacter
Antimicrobial prescribing survey
Antibiotic-resistant gonorrhea
Insurers and antibiotic stewardship
Money for drug-resistance threat
Drug-resistant gonorrhea in Americas
MDR-TB treatment

Apr 21, 2017

Apr 21, 2017

ASP Scan (Weekly) for Apr 21, 2017

Marker for pneumonia antibiotics
MCR-1 cases in Italy
Novel antibiotic target
Penicillin-resistant pneumonia
ID stewardship consults
Steroid for sore throat
MRSA contamination
Chlorhexidine bathing
Candida in Peru
Azithromycin and abnormal heartbeat
Mutations in resistant bacteria

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Nov 14, 2007

Nov 14, 2007

Study finds greater, later role for antivirals in flu patients

(CIDRAP News) – Adults who are hospitalized with serious seasonal influenza infections are more likely to survive if they receive antiviral medications, and older patients may benefit even if treatment is delayed until more than 48 hours after their first symptoms, according to a new study by Canadian researchers.

Sort Results

 

Narrow results

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»